occurred. Even when latex particles with sizes similar to colloidal gold were used for reagent preparation to decrease the sedimentation rate during storage, expensive synthetic materials and tedious covalent-coating procedures were involved, including several ultracentrifugation and sonication steps (22 ) . Once coated and properly stabilized, the colloidal gold particles did not show any sign of nonspecific agglutination. To date, we have used reagent preparations stored at 4°C for Ͼ20 months without any substantial loss in reactivity. The performance of the ferritin assay reported here compares at least equally with other immunoassay technologies, including latex, ELISA, and chemiluminescence.
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In patients with superficial urothelial cell carcinomas (UCCs), 80% of tumors recur after transurethral resection. A minority (10 -20%) of these recurrent tumors will progress to high-grade and muscle-invasive disease (1 ) . Prediction of progression would enable the urologist to determine individual therapy to reduce mortality.
For the detection of recurrent disease, endoscopic evaluation (cystoscopy) is considered the gold standard (1 ) . Cystoscopy is supplemented with urine or bladder wash (7 ) . c Ϫ, no telomerase activity, hTERT mRNA, or malignant cells detectable. For positive samples, based on the intensity of the 6-bp ladder, samples were classified as weakly positive (ϩ), positive (ϩϩ), and strongly positive (ϩϩϩ). d NA, not available.
cytology that can detect cells from carcinoma in situ (CIS) or small high-grade tumors, both of which greatly increase progression risk and frequently are missed with cystoscopy (1, 2 ) . Unfortunately, cytology is susceptible to observer variability, and a more standardized method for exfoliated tumor cell analysis is needed (3 ) .
Telomerase is a promising tumor marker that can be detected in 95% of all UCCs, but not in healthy urothelia (4 ) . However, the relationship between telomerase activity and prognostic indicators, such as stage and grade, is not clear (4 -6 ) . As a more quantitative alternative, we developed a method to assess the expression of the hTERT gene, which codes for the catalytic subunit of telomerase (7 ) . An endogenous control (18S rRNA expression) was included in this assay to normalize for conditions affecting the accurate quantification of hTERT mRNA. Application of the novel method to bladder tissue samples showed that all UCCs, but no healthy urothelia, expressed hTERT (8 ) . Moreover, a significant correlation was found with clinicopathological indices (8 ) . When we applied cutoff values for normalized hTERT, the assay could discriminate between low, medium, and high-grade UCCs (8 ) . This suggested that the presence of hTERT mRNA is not only a diagnostic marker, but when quantified accurately, may also be used as a prognostic marker. In this study, we investigated whether aggressive exfoliated tumor cells can be identified by quantification of hTERT mRNA or telomerase activity in bladder washings of patients with recurrent UCC.
Bladder washings for cytology were obtained during cystoscopy from 40 of 42 patients suspected for UCC. Before transurethral resection of the suspected tumor, a second bladder washing (100 mL) was collected and immediately cooled on ice. Cells from these latter washings were washed twice with ice-cold phosphate-buffered saline and were finally suspended in ice-cold phosphate-buffered saline containing 15 mL/L fetal calf serum. Urothelial cells were enriched with 30 L of magnetic beads (3 ϫ 10 7 particles), coated with an antibody (Ber-EP4) against epithelial cells (Dynal). After incubation for 30 min at 4°C and subsequent magnetic separation, bead-bound urothelial cells were washed three times with phosphate-buffered saline containing 15 mL/L fetal calf serum. Beads (with attached urothelial cells) were divided into two equal parts, snap-frozen in liquid nitrogen, and stored at Ϫ80°C. As specificity controls, bladder washings from 14 catheterized tumor-free patients were collected, processed, and stored. All samples were coded before analysis for telomerase activity and hTERT expression. After analysis, the code was broken and results were compared with pathological reports.
We measured telomerase activity on one part of the stored bead-cell pellet, according to instructions for the telomeric repeat amplification protocol (TRAP; TRAPeze reagent set; Intergen). After the addition of lysis buffer, the protein content of the lysate was determined using Coomassie Brilliant Blue (Bio-Rad). Three different protein concentrations (0.2, 2.0, and 6.0 g) were used. After 33 PCR cycles, amplicons were detected with a native 15% polyacrylamide gel and silver staining. The presence and intensity of the 6-bp DNA ladders for each of the three protein concentrations determined whether a sample was classified as negative (Ϫ) or positive (ϩ, ϩϩ, or ϩϩϩ). Samples classified as ϩ were reanalyzed.
Total RNA was isolated from the second part of the bead-cell pellet using Trizol (Life Technologies) and 2.0 g of poly(A) RNA as precipitation carrier. After the manufacturer's protocol was completed, RNA was dissolved in 20 L of RNase-free water. One-half of the RNA (10 L) was denatured at 90°C for 5 min and cooled on ice. Reverse transcriptase mixture (10 L) was added, containing reverse transcriptase buffer, 25 U of Multi- Scribe reverse transcriptase, 8 units of RNase inhibitor, 2.5 mol/L dN 6 , 500 mol/L deoxynucleotides, and 5.5 mol/L MgCl 2 (all components from Perkin-Elmer). Conditions for cDNA synthesis were as follows: 10 min at 25°C, 30 min at 48°C, and 5 min at 95°C. Real-time quantitative PCR reaction conditions and data analysis for 18S rRNA and hTERT mRNA were described previously (7 ) .
The presence of UCC could be confirmed by pathology in 36 patients but not in 6 ( Table 1) . Pathological reports were used as the criteria for tumor presence, grade, and stage.
In the cytology reports of 34 patients with UCC, tumor cells were detected in 13 (38%) bladder washings and suspected in 11 (32%; Table 1 ). Most grade III tumors (8 of 13; 62%) were correctly identified as high grade. Tumor cells were also observed or suspected in the bladder washings of three patients without pathological evidence of tumor.
Telomerase activity in washings was detected in 19 (53%) patients with confirmed UCC (Table 1 ). In one sample, negative for pathology (case 6), a 6-bp ladder was seen in duplicate experiments. In the bladder washings of patients with high-grade tumors, the sensitivity was 77% (10 of 13). However, we could not discriminate these high-grade malignant cells from lower-grade cells by the intensity of the 6-bp ladder. In 14 bladder washings from nonmalignant specificity controls, no telomerase activity was observed.
Overall sensitivity for the detection of hTERT mRNA was similar to telomerase activity: 18 of 36 (50%) wash samples from patients with confirmed UCC contained hTERT mRNA and had total overlap with positive telomerase activity data. In one bladder washing (case 6), hTERT mRNA was detected. Because this sample was also positive for both TRAP and cytology, we suspect the tumor was missed during transurethral resection. Nonmalignant controls did not contain hTERT mRNA in the washings. In patients with grade III tumors, hTERT mRNA was present in 10 of 13 (77%) washings. Quantitative hTERT mRNA measurement could discriminate these tumors from lower-grade tumors, using a hTERT cutoff of 6.80, as determined previously (8 ) . Seven of 13 (54%) washings of patients with grade III tumors had normalized hTERT expression above cutoff, whereas only 1 of 23 (4%) washings of patients with lower-grade tumors was above 6.80 (Fig. 1) .
In this study, we examined telomerase activity and hTERT mRNA in bladder washings as markers for highgrade superficial UCCs, which are at high risk for progression into muscle-invasive disease. Telomerase activity measurements could not discriminate grade III from lower-grade tumors. This reflects most reports in the literature, where no relationship was found between telomerase activity and tumor grade or stage as prognostic indicators (5, 6 ) . Lack of correlation could be attributed to limitations of the TRAP, e.g., the absence of a control for RNA template degradation, and endpoint quantification of PCR amplicon formation (9 ) . In contrast, the method for hTERT mRNA quantification contains an endogenous control that normalizes for various conditions that affect the assay (7 ) . Accurate quantification is also obtained by measurement in the exponential phase of the PCR. Using this method, we showed in a previous study that normalized hTERT mRNA amounts correlated with clinicopathological indicators in UCC (8 ) . A cutoff value of 6.80 was determined to discriminate between grade III and lowergrade tumors. This discrimination is important clinically because (untreated) high-grade superficial tumors have a high progression rate to muscle-invasive disease; 25% for stage T a , 50% for stage T 1 tumors, and 60% for CIS (1 ) .
Typically, when we applied the same hTERT cutoff in bladder washings, 54% of bladder washings from patients with grade III tumors (including CIS) contained normalized hTERT values above the cutoff, whereas only 4% of the lower-grade tumors were above the cutoff (Fig. 1) . Sensitivity of the hTERT assay for the detection of highgrade cells was higher than cytology (77% vs 62%), and hTERT expression above cutoff may specifically identify those high-grade tumors that will progress. Moreover, quantification of hTERT is standardized (by use of a computer), which reduces inter-and intraobserver variability compared with cytology.
The enrichment of urothelial cells from washings was necessary to remove contaminating blood cells that affect quantification. This enrichment may have led to lower sensitivity than reported in the literature for the detection of bladder cancer (10 ) . However, we did not aim for a sensitive diagnostic test to replace cystoscopy, but rather aimed for a test to supplement cystoscopy for the specific identification of aggressive tumors. Therefore, bladder washings obtained during cystoscopy could be used, whereas only urine is of interest as a noninvasive diagnostic modality (11 ) .
We conclude that quantification of hTERT expression in bladder washings can identify recurrent high-grade tumors that are at high risk for progression. Follow-up monitoring and a larger study will be necessary to substantiate whether hTERT quantification in bladder washings can accurately predict tumor progression.
